In summary, our MR analysis results suggest that the genetically predicted cathepsin H has an inhibitory effect on major subtypes of malignant skin tumors such as melanoma and CSCC, but further exploration is needed to understand its role in BCC. This evidence concerns the gene CTSH and skin basal cell carcinoma.